

Fundamental dimension Equity attribute | COFLeader $200.38▼-1.50% Cap $122.9BP/E 11.8x QuantScore62/100 | AXPPeer $313.03▼-3.73% Cap $211.4BP/E 17.6x QuantScore55/100 | BACPeer $50.75▼-0.66% Cap $354.8BP/E 11.9x QuantScore50/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
68/100 |
57/100 |
28/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 77/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 36/100 | 60/100 | 28/100 |
Growth Revenue / earnings growth & margins | 48/100 | 40/100 | 38/100 |
Sentiment Analyst ratings, targets & revisions | 59/100 | 39/100 | 79/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 11.8x | 17.6x | 11.9x |
Forward P/E (next FY) | 9.4x | 17.8x | 11.6x |
EV / EBITDA (TTM) | 5.8x | 8.5x | 15.6x |
Price / Sales | 1.6x | 2.5x | 1.8x |
Price / Free Cash Flow | 3.8x | 14.4x | 3.7x |
PEG ratio | 0.02 | 0.89 | 0.82 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 9 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | -0.12 (Distress) | 1.32 (Distress) | 0.27 (Distress) |
Total debt / equity | 0.45 | 0.19 | 1.28 |
Quick ratio | 0.3x | 34.1x | 0.4x |
Interest coverage | 1.0x | 3.0x | 0.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +28.4% | +8.4% | -0.5% |
Net income growth YoY | -48.4% | +7.0% | +12.4% |
Gross margin (TTM) | 66.6% | 85.2% | 60.4% |
Operating margin (FY) | 3.3% | 17.1% | 19.7% |
FCF margin (FY) | 37.7% | 19.9% | 6.6% |
5. Trailing price performancePrice change over period |
1M return | +2.4% | +3.7% | -9.8% |
3M return | -0.7% | -8.2% | -18.5% |
6M return | +5.2% | -1.7% | -2.9% |
Year to date | -16.9% | -15.4% | -8.1% |
1Y return | -10.5% | -11.8% | -3.8% |
3Y return | +125.7% | +116.5% | +98.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $574.80 +186.9% upside | $203.77 -34.9% premium | $30.30 -40.3% premium |
Wall Street consensus target | $251.78 +25.7% · range $220.00–$280.00 | $360.50 +15.2% · range $315.00–$400.00 | $66.00 +30.1% · range $60.00–$75.00 |
Consensus stance | 63% Buy30% Hold7% Sell | 40% Buy53% Hold7% Sell | 65% Buy33% Hold2% Sell |